Study of Sleep Disorders in Prodromal and Definite Parkinsons Disease

NCT ID: NCT06582121

Last Updated: 2025-05-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

457 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-03-18

Study Completion Date

2028-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Multicenter controlled study of sleep disorders in isolated REM Behavior Disorder and Parkinson\'s disease (SOMPARK)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Sleep disturbances are common and understudied in established or prodromal Parkinson\'s disease. The purpose of this study is to systematically and comprehensively determine the clinical characteristics and electrophysiologic patterns of the major sleep disorders in PD and isolated RBD.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease REM Sleep Behavior Disorder (iRBD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

All participant will do polysomnographies during a 2-days stay in hospital with electroencephalogram, electromyogram and questionnaries. The urine will be also collected during 2 days.
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participants

Study of the sleep with polysomnography during a 2-days stay in hospital. Other exam will be done during the 2 days.

Group Type EXPERIMENTAL

Polysomnography

Intervention Type OTHER

An overnight sleep study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Polysomnography

An overnight sleep study

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Biology (urine, blood, faeces) Questionnaries electromyogram electroencephalogram

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Common to all groups:

* Age superior 18 years
* Patients who have received complete information about the study from an investigator and who fully consent to participate.

For Parkinson Disease (PD):

* Patients followed for PD diagnosed according to international criteria for the diagnosis of PD (MDS criteria),
* A MoCA score greater than 20/30
* No treatment with deep brain stimulation.

For REM Sleep Behavior Disorder (RBD):

* Diagnosis of RBD according to ICSD-3 criteria: presence on polysomnography of an abnormal elevation of muscle tone during REM sleep (more than 18% of REM sleep without chin atonia) and/or the presence of REM sleep behaviors on video-polysomnography,
* Absence of progressive neurodegenerative pathology: absence of diagnostic criteria for PD, multiple system atrophy, or Lewy body dementia.

For healthy controls:

\- No neurological or psychiatric disease

Exclusion Criteria

Common to all groups:

* Pregnant or breastfeeding women
* Subjects under guardianship/conservatorship
* Persons deprived of liberty.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Clermont-Ferrand

Clermont-Ferrand, , France

Site Status NOT_YET_RECRUITING

CHU de Lille

Lille, , France

Site Status NOT_YET_RECRUITING

CHU de Lyon

Lyon, , France

Site Status NOT_YET_RECRUITING

CHU de Nantes

Nantes, , France

Site Status NOT_YET_RECRUITING

CHU de Nîmes

Nîmes, , France

Site Status NOT_YET_RECRUITING

CHU Pitié Salpêtrière

Paris, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Isabelle ARNULF, Prof

Role: CONTACT

+33 (0)1 42 16 77 04

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Maria-Livia FANTINI, MD

Role: primary

+33 (0)4 73 75 16 66

Lise LANVIN, MD

Role: primary

+33 (0)3 20 44 63 62

Laure PETER-DEREX, MD

Role: primary

+33 (0)4 72 07 17 69

Laurène LECLAIR-VISONNEAU, MD

Role: primary

+33 (0)2 40 16 55 10

Beatriz ABRIL, MD

Role: primary

+33 (0)4 66 68 39 00

Pauline DODET, MD

Role: primary

+33(0)142167702

Stéphane ATTARD, CRA

Role: backup

+33(0)142167712

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

APHP230127

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evolution of RBD in PD
NCT03047408 UNKNOWN NA
Sleep, Awake & Move - Part II
NCT02710487 COMPLETED NA
Prevention-in-PD-Study
NCT07297407 NOT_YET_RECRUITING NA